Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VER-A-T1D trial of verapamil SR in newly diagnosed adult type 1 diabetes
2023-506545-27-01Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Verapamil SR with Placebo (2 arms). Primary endpoint: Stimulated C-peptide AUC at 12 months. Started Jan 2025; status: completed.
02
Drugs
verapamil
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2023-506545-27-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506545-27-01.